JAK2 and myeloid neoplasm: Previous research from Dr. Wei Tong’s laboratory has shown that ubiquitination of JAK2 by CBL and CBL-B regulates the stability and activity of the JAK2 protein, playing a critical role in curbing HSPC expansion and preventing the development of myeloid malignancies (18).